Join
Live feed
·
INSIDERFilingvia Quantisnow
Sensei Biotherapeutics Inc. logo

Director Hahn Stephen M. converted options into 44,763 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SNSE· Sensei Biotherapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SNSE (Sensei Biotherapeutics Inc.) and more on Quantisnow.